311 related articles for article (PubMed ID: 25885538)
1. Comparison of MAPK specificity across the ETS transcription factor family identifies a high-affinity ERK interaction required for ERG function in prostate cells.
Selvaraj N; Kedage V; Hollenhorst PC
Cell Commun Signal; 2015 Feb; 13():12. PubMed ID: 25885538
[TBL] [Abstract][Full Text] [Related]
2. ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells.
Plotnik JP; Budka JA; Ferris MW; Hollenhorst PC
Nucleic Acids Res; 2014 Oct; 42(19):11928-40. PubMed ID: 25294825
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of the oncogenic transcription factor ERG in prostate cells dissociates polycomb repressive complex 2, allowing target gene activation.
Kedage V; Strittmatter BG; Dausinas PB; Hollenhorst PC
J Biol Chem; 2017 Oct; 292(42):17225-17235. PubMed ID: 28887309
[TBL] [Abstract][Full Text] [Related]
4. Epiregulin expression by Ets-1 and ERK signaling pathway in Ki-ras-transformed cells.
Cho MC; Choi HS; Lee S; Kim BY; Jung M; Park SN; Yoon DY
Biochem Biophys Res Commun; 2008 Dec; 377(3):832-7. PubMed ID: 18948081
[TBL] [Abstract][Full Text] [Related]
5. Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment.
Foulds CE; Nelson ML; Blaszczak AG; Graves BJ
Mol Cell Biol; 2004 Dec; 24(24):10954-64. PubMed ID: 15572696
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer ETS rearrangements switch a cell migration gene expression program from RAS/ERK to PI3K/AKT regulation.
Selvaraj N; Budka JA; Ferris MW; Jerde TJ; Hollenhorst PC
Mol Cancer; 2014 Mar; 13():61. PubMed ID: 24642271
[TBL] [Abstract][Full Text] [Related]
7. Ras/ERK and PI3K/AKT signaling differentially regulate oncogenic ERG mediated transcription in prostate cells.
Strittmatter BG; Jerde TJ; Hollenhorst PC
PLoS Genet; 2021 Jul; 17(7):e1009708. PubMed ID: 34314419
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
[TBL] [Abstract][Full Text] [Related]
9. ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer.
Kunderfranco P; Mello-Grand M; Cangemi R; Pellini S; Mensah A; Albertini V; Malek A; Chiorino G; Catapano CV; Carbone GM
PLoS One; 2010 May; 5(5):e10547. PubMed ID: 20479932
[TBL] [Abstract][Full Text] [Related]
10. Dynamic regulation of VEGF-inducible genes by an ERK/ERG/p300 transcriptional network.
Fish JE; Cantu Gutierrez M; Dang LT; Khyzha N; Chen Z; Veitch S; Cheng HS; Khor M; Antounians L; Njock MS; Boudreau E; Herman AM; Rhyner AM; Ruiz OE; Eisenhoffer GT; Medina-Rivera A; Wilson MD; Wythe JD
Development; 2017 Jul; 144(13):2428-2444. PubMed ID: 28536097
[TBL] [Abstract][Full Text] [Related]
11. Signal transduction and the Ets family of transcription factors.
Yordy JS; Muise-Helmericks RC
Oncogene; 2000 Dec; 19(55):6503-13. PubMed ID: 11175366
[TBL] [Abstract][Full Text] [Related]
12. ETS transcription factors and prostate cancer: the role of the family prototype ETS-1 (review).
Adler D; Wernert N
Int J Oncol; 2012 Jun; 40(6):1748-54. PubMed ID: 22366814
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of the P-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways.
Pestell RG; Albanese C; Watanabe G; Lee RJ; Lastowiecki P; Zon L; Ostrowski M; Jameson JL
Mol Endocrinol; 1996 Sep; 10(9):1084-94. PubMed ID: 8885243
[TBL] [Abstract][Full Text] [Related]
15. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
Bardwell AJ; Abdollahi M; Bardwell L
Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
[TBL] [Abstract][Full Text] [Related]
16. A Raf/MEK/ERK signaling pathway is required for development of the sea urchin embryo micromere lineage through phosphorylation of the transcription factor Ets.
Röttinger E; Besnardeau L; Lepage T
Development; 2004 Mar; 131(5):1075-87. PubMed ID: 14973284
[TBL] [Abstract][Full Text] [Related]
17. ERG is specifically associated with ETS-2 and ETV-4, but not with ETS-1, in prostate cancer.
Adler D; Ochsenfahrt J; Fuchs K; Kristiansen G; Perner S; Wernert N
Int J Mol Med; 2012 Nov; 30(5):1029-33. PubMed ID: 22922762
[TBL] [Abstract][Full Text] [Related]
18. Local destabilization, rigid body, and fuzzy docking facilitate the phosphorylation of the transcription factor Ets-1 by the mitogen-activated protein kinase ERK2.
Piserchio A; Warthaka M; Kaoud TS; Callaway K; Dalby KN; Ghose R
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):E6287-E6296. PubMed ID: 28716922
[TBL] [Abstract][Full Text] [Related]
19. ERG upregulation and related ETS transcription factors in prostate cancer.
Rostad K; Mannelqvist M; Halvorsen OJ; Oyan AM; Bø TH; Stordrange L; Olsen S; Haukaas SA; Lin B; Hood L; Jonassen I; Akslen LA; Kalland KH
Int J Oncol; 2007 Jan; 30(1):19-32. PubMed ID: 17143509
[TBL] [Abstract][Full Text] [Related]
20. Ras signaling requires dynamic properties of Ets1 for phosphorylation-enhanced binding to coactivator CBP.
Nelson ML; Kang HS; Lee GM; Blaszczak AG; Lau DK; McIntosh LP; Graves BJ
Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10026-31. PubMed ID: 20534573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
